» Authors » Friederike Sixel-Doring

Friederike Sixel-Doring

Explore the profile of Friederike Sixel-Doring including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 80
Citations 2240
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Concha-Marambio L, Weber S, Farris C, Dakna M, Lang E, Wicke T, et al.
Mov Disord . 2023 Feb; 38(4):567-578. PMID: 36781413
Background: Misfolded α-synuclein (αSyn) aggregates (αSyn-seeds) in cerebrospinal fluid (CSF) are biomarkers for synucleinopathies such as Parkinson's disease (PD). αSyn-seeds have been detected in prodromal cases with isolated rapid eye...
12.
Yu E, Krohn L, Ruskey J, Asayesh F, Spiegelman D, Shah Z, et al.
medRxiv . 2023 Feb; PMID: 36778313
Background And Objectives: Isolated/idiopathic REM sleep behavior disorder (iRBD) and Lewy body dementia (LBD) are synucleinopathies that have partial genetic overlap with Parkinson's disease (PD). Previous studies have shown that...
13.
Cesari M, Heidbreder A, St Louis E, Sixel-Doring F, Bliwise D, Baldelli L, et al.
Sleep . 2022 Dec; 46(1). PMID: 36519899
No abstract available.
14.
Krohn L, Heilbron K, Blauwendraat C, Reynolds R, Yu E, Senkevich K, et al.
Nat Commun . 2022 Dec; 13(1):7496. PMID: 36470867
Rapid-eye movement (REM) sleep behavior disorder (RBD), enactment of dreams during REM sleep, is an early clinical symptom of alpha-synucleinopathies and defines a more severe subtype. The genetic background of...
15.
Pinto S, Nebel A, Rau J, Espesser R, Maillochon P, Niebuhr O, et al.
Mov Disord . 2022 Dec; 38(2):212-222. PMID: 36461899
Background: The EARLYSTIM trial demonstrated for Parkinson's disease patients with early motor complications that deep brain stimulation of the subthalamic nucleus (STN-DBS) and best medical treatment (BMT) was superior to...
16.
Bartl M, Dakna M, Schade S, Otte B, Wicke T, Lang E, et al.
Mov Disord . 2022 Oct; 38(1):68-81. PMID: 36267007
Background: Recent studies point toward a significant impact of cardiovascular processes and inflammation on Parkinson's disease (PD) progression. Objective: The aim of this study was to assess established markers of...
17.
Weiss D, Landoulsi Z, May P, Sharma M, Schupbach M, You H, et al.
Parkinsonism Relat Disord . 2022 Sep; 103:169-174. PMID: 36117018
Purpose: The decision for subthalamic deep brain stimulation (STN-DBS) in Parkinson's disease (PD) relies on clinical predictors. Whether genetic variables could predict favourable or unfavourable decisions is under investigation. Objective:...
18.
Schutz L, Sixel-Doring F, Hermann W
J Parkinsons Dis . 2022 Aug; 12(7):2029-2058. PMID: 35938257
Parkinson's disease (PD) is defined by its motor symptoms rigidity, tremor, and akinesia. However, non-motor symptoms, particularly autonomic disorders and sleep disturbances, occur frequently in PD causing equivalent or even...
19.
Poggiolini I, Gupta V, Lawton M, Lee S, El-Turabi A, Querejeta-Coma A, et al.
Brain . 2021 Dec; 145(2):584-595. PMID: 34894214
Several studies have confirmed the α-synuclein real-time quaking-induced conversion (RT-QuIC) assay to have high sensitivity and specificity for Parkinson's disease. However, whether the assay can be used as a robust,...
20.
Cesari M, Heidbreder A, St Louis E, Sixel-Doring F, Bliwise D, Baldelli L, et al.
Sleep . 2021 Oct; 45(3). PMID: 34694408
Video-polysomnography (v-PSG) is essential for diagnosing rapid eye movement (REM) sleep behavior disorder (RBD). Although there are current American Academy of Sleep Medicine standards to diagnose RBD, several aspects need...